These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12917315)
21. Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy. Merito M; Giorgi Rossi P; Mantovani J; Curtale F; Borgia P; Guasticchi G Vaccine; 2007 Jan; 25(3):458-65. PubMed ID: 17049685 [TBL] [Abstract][Full Text] [Related]
22. Effects of pneumococcal vaccination on hospitalization and exacerbations in elderly Japanese chronic obstructive pulmonary disease patients. Yamaya M; Fujino N; Kubo H; Arai H Geriatr Gerontol Int; 2009 Jun; 9(2):206-9. PubMed ID: 19490143 [No Abstract] [Full Text] [Related]
23. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence. Fedson DS Lancet Infect Dis; 2003 May; 3(5):272-3; discussion 273-4. PubMed ID: 12726973 [No Abstract] [Full Text] [Related]
24. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine. Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273 [TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan. Cai L; Uchiyama H; Yanagisawa S; Kamae I Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372 [TBL] [Abstract][Full Text] [Related]
27. Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands. Postma MJ; Heijnen ML; Beutels P; Jager JC Expert Rev Vaccines; 2003 Aug; 2(4):477-82. PubMed ID: 14711333 [TBL] [Abstract][Full Text] [Related]
29. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981 [TBL] [Abstract][Full Text] [Related]
30. Cost benefits of targeting the pneumococcal vaccination program to the elderly population in Taiwan. Chen YH; Yang GY; Loh CH; Liou SH; Su WL; Lin SH; Chou CC Am J Infect Control; 2006 Nov; 34(9):597-9. PubMed ID: 17097456 [TBL] [Abstract][Full Text] [Related]
31. Pneumococcal vaccination. de Roux A; Lode H Eur Respir J; 2005 Dec; 26(6):982-3. PubMed ID: 16319323 [No Abstract] [Full Text] [Related]